|Study Type:||Phase I|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase I dose-escalation clinical trial to evaluate the safety and immunogenicity of a multiclade, multivalent recombinant adenoviral vector HIV vaccine, VRC-HIVADV014-00-VP, in healthy, HIV-1 uninfected adult participants who have low titers of pre-existing Ad5 neutralizing antibodies
HVTN 054 is a Phase I clinical trial to evaluate the safety and immunogenicity of VRC-HIVADV014-00-VP (rAd5).
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.